Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Medical device tax: Is the White House changing its tone?
Mass Device
Friday, October 11, 2013 - 9:40am
tags:
device tax, healthcare reform, devices
Osiris exits stem cell business, sells unit to Mesoblast in $100M deal
Fierce Biotech
Friday, October 11, 2013 - 9:39am
tags:
Mesoblast, Osiris, stem cells, M&A
Psoriasis study does little to help Pfizer with Xeljanz
Fierce Pharma
Friday, October 11, 2013 - 9:37am
tags:
Pfizer, psoriasis, Xeljanz
Analysts' Actions: AIZ GLW JNJ LLY MRK
Yahoo/TheStreet.com
Friday, October 11, 2013 - 9:35am
tags:
JNJ, Eli Lilly, Merck, Pharmacyclics
Celladon, Xencor bid for $155M in red-hot IPO market
Fierce Biotech
Friday, October 11, 2013 - 9:00am
tags:
IPOs, Celladon, Xencor, Mydicar, XmAb
3 Things Biotech Investors Can't Do With the Government Shutdown
Motley Fool
Friday, October 11, 2013 - 8:58am
tags:
Ariad Pharmaceuticals, Merck, Amarin, advisory panels, FDA
Vivus, Auxilium sign $300 mln deal for erectile dysfunction drug
Reuters
Friday, October 11, 2013 - 8:57am
tags:
Vivus, erectile dysfunction, Auxilium, Stendra
CSL Pays $64M To Settle Antitrust Suit Over Plasma Pricing
Pharmalot
Friday, October 11, 2013 - 8:56am
tags:
CSL, plasma-based pharmaceuticals, antitrust
Alkermes depression drug gets fast track status
Bloomberg/Businessweek
Friday, October 11, 2013 - 8:53am
tags:
Alkermes, fast track, ALKS 5461, antidepressants, major depressive disorder
Make It Or Break It Day Could Be At Hand For Amarin
Seeking Alpha
Friday, October 11, 2013 - 8:51am
tags:
Amarin, FDA, Vascepa
The Big Bucks in Keeping Kids Focused
Bloomberg/Businessweek
Friday, October 11, 2013 - 8:50am
tags:
ADHD, Shire, Vyvanse, Novartis, JNJ, Europe
Earnings Preview: J&J to report 3Q results Tuesday
Yahoo/AP
Friday, October 11, 2013 - 8:48am
tags:
JNJ, earnings
AstraZeneca to co-promote J&J prostate cancer drug in Japan
Yahoo/Reuters
Friday, October 11, 2013 - 8:47am
tags:
JNJ, AstraZeneca, Japan, prostate cancer, abiraterone
Genmab announces positive results for sclerosis drug candidate
Reuters
Thursday, October 10, 2013 - 6:19pm
tags:
Genmab, MS, multiple sclerosis, ofatumumab
Janssen Purchase Doesn't Change Case For Idenix
Seeking Alpha
Thursday, October 10, 2013 - 6:17pm
tags:
Janssen, Idenix, IDX719
Antares' Otrexup Ready For FDA Approval
Seeking Alpha
Thursday, October 10, 2013 - 11:55am
tags:
Otrexup, FDA, rheumatoid arthritis, Antares, devices
Google visionaries ready to invest a fortune in revolutionizing aging process
Fierce Biotech
Thursday, October 10, 2013 - 11:31am
tags:
Google, Calico, aging
Is There a Biotech Bubble?
Barron's
Thursday, October 10, 2013 - 11:27am
tags:
biotech
Quest Diagnostics says third-quarter profit to miss estimates
Reuters
Thursday, October 10, 2013 - 11:21am
tags:
Quest Diagnostics, diagnostics
Why Did This Big Pharma Outperform Its Industry Peers?
Motley Fool
Thursday, October 10, 2013 - 11:19am
tags:
Pfizer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.